ATLAS-seq: a microfluidic single-cell TCR screen for antigen-reactive TCRs
Abstract Discovering antigen-reactive T cell receptors (TCRs) is central to developing effective engineered T cell immunotherapies. However, the conventional technologies for isolating antigen-reactive TCRs (i.e., major histocompatibility complex (MHC) multimer staining) focus on high-affinity inter...
Saved in:
Main Authors: | Siwei Luo, Amber Notaro, Lan Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-024-54675-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preclinical model for evaluating human TCRs against chimeric syngeneic tumors
by: Olivier Michielin, et al.
Published: (2024-12-01) -
Human TCR repertoire in cancer
by: Lin Chen, et al.
Published: (2024-09-01) -
TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy
by: Marco Donia, et al.
Published: (2023-08-01) -
Modifications to rhesus macaque TCR constant regions improve TCR cell surface expression.
by: Lori V Coren, et al.
Published: (2025-01-01) -
Tolerance in TCR/Cognate Antigen Double-TransgenicMice Mediated by Incomplete Thymic Deletion andPeripheral Receptor Downregulation
by: Clio Mamalaki, et al.
Published: (1995-01-01)